Abstract-The S-layer, crystalline arrays of proteinaceous subunits, seems to be a typical surface structure in several lactobacilli species. Due their self-assembly ability to recrystallize into isoporous monolayers in suspension, at liquid-surface interfaces, lipid structures and on solid supports, S-layers were demonstrated to possess a great potential for nanobiotechnological applications. Interest in lactobacilli S-layer has been reinforced by claimed and demonstrated probiotic properties for human and animal consumers. Several lactobacillar S-layer have been found to be involved in adherence to intestinal epithelial cells and to the mammalian extracellular matrix. Due to these observed adhesive properties, the possible therapeutic applications of lactobacillar S-layers have become increasingly of interest, e.g. as targeted antigen delivery vehicles to host tissues. In addition, S-layers may provide superior expression levels and surface density of antigens when compared to other bacterial antigen presentation systems. It has already been demonstrated that S-layer protein subunits can be modified to carry foreign epitopes as a uniform recombinant S-layer on the Lactobacillus cell surface. The adhesion and immunogenic functions of S-layer proteins, combined with the properties of Lactobacillus spp., could lead to new, safe, and stable liposomal particles for drug delivery.
INTRODUCTION
Lactobacilli are Gram-positive, rod-shaped members of the lactic acid bacteria (LAB) group; they are characterized by the formation of lactic acid as the sole or main product of sugar fermentation. They are found where rich, carbohydrate-containing substances are available; hence LAB occur in a wide variety of habitats such as the mucosal membranes of humans and animals (oral cavity, vagina and gastrointestinal tract), on plants, in manure and man-made habitats such as sewage and fermented or spoiled food [ [1] , 2]. The food and feed industry utilizes lactobacilli widely in different fermentative processes [[3] ]. Due to their long history of use in food fermentation and in the food industry, and because of their lack of pathogenicity, lactobacilli are 'generally recognized as safe' (GRAS) organisms [[4] ]. One of the outer surface components of cell envelopes of prokaryotic organisms, archaea and bacteria, are crystalline arrays of proteinaceous subunits, known as surface layers (S-layers), which usually are composed of single protein or glycoprotein species [[5] , [6] , [7] ]. S-layer proteins have the capability to recrystallize into isoporous monolayers in suspension, at liquid-surface interfaces, lipid structures and on solid supports. Due their selfassembly ability, S-layers were demonstrated to possess a great potential for nanobiotechnological applications. The S-layer seems to be a typical surface structure in several lactobacilli species [[4] ]. Interest in lactobacilli S-layer has been reinforced by claimed and demonstrated probiotic properties for human and animal consumers [1, 8] . The aim of the present work is to organize the vast information concerning S-layer proteins, particularly S-layers from lactobacilli, spotlighting/underlining those aspects related to properties that make them attractive candidates for mucosal vaccine-delivery vehicles.
S-layer proteins: Generalities 1.1 Location and ultrastructure
When present, S-layers completely surround cells as the outermost component of their envelope, except for the organisms witch posses capsule like Bacillus anthracis, where the capsule is the external structure [ [9] ]. They have been described in most of the main branches of the Bacteria and Archaea domains [ [9] , [11] , [12] ]. In archaea, S-layer lattices often constitute the only cell wall component, and some of them are anchored by pillar-like domains to the plasma membrane [ [13] ]. In Gram-positive bacteria, the lattice assembles on the surface of the cell wall, which is composed mainly of peptidoglycan. In Gram-negative bacteria, the S-layer is attached to the lipopolysaccharide (LPS) component of the outer membrane [[14] ]. Some Gram-positive and Gram-negative bacteria can produce two superimposed S-layers; usually, each is composed of a different subunit species [[15] [ [16] , [17] ]. Most S-layers consist of a single protein or glycoprotein that polymerizes to form bidimensional paracrystalline structures. Only a few organisms, including Clostridium difficile and B. anthracis, have S-layer proteins with two types of subunits [[18] , [19] , [20] ]. Electron microscopy of negative staining or freezeetched preparations, Fig. (2) , are necessary to identify S-layers [ [15] ]. High-resolution studies on the mass distribution of lattices are generally made with negatively stained, frozen S-layer fragments, or with recrystallized S-layer lattices. Surface topography of S-layers can also be studied through atomic force microscopy (AFM), which is increasingly used to investigate the forces within or between single biomolecules [ [21] ]. The S-layer crystal lattice may have oblique (p1, p2), tetragonal (p4), or hexagonal (p3, p6) symmetry. Depending on the pattern, a morphological unit of the S-layer consists of one, two, three, four, or six protein subunits, Fig. (3) . Center-to-center spacing of the morphological units can vary from 2.5 to 35.0 nm; thus, the lattices can be quite porous, with pores occupying up to ∼70% of their surface. The pores within an S-layer are of identical size (usually in the 2-8 nm range) and shape. Frequently, two or more distinct classes of pores are present. A common feature of Slayers is their smooth outer surface and more corrugated inner surface. Most S-layer subunits are weakly acidic proteins, and thus showed a charge-neutral outer and a net-negative inner face at a neutral pH [[16] ].
Isolation and self-assembly
Interactions between S-layer subunits, as well as between the S-layer and the supporting envelope, can be disrupted in a reversible manner by cation substitution or by a high concentration of chaotropic agents [ [22] , [14] ]. This demonstrates that individual S-layer subunits interact with each other and with the supporting cell envelope components through noncovalent bonding. Isolated S-layer subunits frequently maintain the ability to recrystallize into regular arrays in suspension or on surfaces after removal of the isolation agent. These arrays obtained in vitro exhibit structural features that are often indistinguishable from those found surrounding the cells in vivo. Slayers differ considerably in their susceptibility to disruption into monomeric subunits. They are normally isolated from purified cell wall fragments by the addition of hydrogenbond-breaking agents (urea or guanidine hydrochloride), detergents (at pH <4.0) or by cation substitution (e.g. Na+ or Li+ replacing Ca2+) [[14] ]. Intersubunit bonds are stronger than those that bind the lattice to the underlying envelope layer; this property is a basic requirement for continuous recrystallization of the lattice during cell growth [ [15] , [24] ]. Table 1 ). These bacteria may express alternative S-layer protein genes, probably to adapt to different stress factors, such as drastic changes in the environmental conditions. Generally, S-layer variation is a consequence of DNA rearrangements; however, variation of S-layer protein content in L. brevis ATCC 14869 occurs through a unique mechanism involving activation of transcription by a soluble factor, constituting response to changes in the environment [[17] ]. Multiple genes coding for Slayer proteins is a feature that lactobacilli share with other bacteria, including Bacillus anthracis [[38] ], Clostridium fetus [ [39] ] and Tannerella forsythia [[40] ]. In S-layer proteins of lactobacilli, no SLH motifs have been detected but the attachment of the S-layer protein to the cell wall seems to involve also secondary cell wall polymers in several species [[27] ]. The Slayer proteins from L. brevis and L. buchneri are reported to bind to a neutral polysaccharide moiety of the cell wall [ [41] , [42] ]. Interaction studies performed with truncated rSlpA of L. brevis ATCC 8287 confirmed that N-terminal region of S-layer protein is responsible to cell wall binding [[43] ]. On the other hand, the location of the cell wall binding domain of the L. acidophilus ATCC 4356 SlpA and L. crispatus JCM 5810 CbsA has been determined to reside in the C-terminal one third of these proteins. Interactions between a positively charged Slayer protein region and negatively charged secondary cell wall polymers have been shown to mediate the cell wall binding in the case of SlpA of L. acidophilus ATCC 4356 [ [44] ] and CbsA of L. crispatus JCM 5810 [ [45] ]. It was shown that SlpA and CbsA bind to teichoic acids, and CbsA binds also to lipoteichoic acids purified from Staphylococcus aureus and Streptococcus faecalis, but not to the teichuronic acid/polysaccharide fraction of the cell wall of L. crispatus JCM 5810 [45] .
S-layer glycoproteins in lactobacilli
Glycosylation represents the most common post-translational modification in S-layer proteins and it has been demonstrated in many archaeal and bacterial genera. Although most of S-layers from lactobacilli appear to be nonglycosylated [4] [48] ] have been proposed that glycosylation on S-layer protein of L. kefiri could be related with the aggregation ability of these bacteria. Furthermore, the presence of glycosidic groups on this bacterium seems to be related with a higher affinity of these proteins with positively charged lipid membranes [[53] ]. However, further studies should be made in order to clarify the specific relationship between glycosylation and affinity features of S-layer proteins from L. kefiri. Besides these effects, it has been reported that glycosylation contributes to protein antigenic properties [20] , an interesting feature in the development of a vaccine carrier. Glycoengineering applications appears as a novel and interesting field of study that may include receptor mimics, vaccine design, or drug delivery using carbohydrate recognition [30] . Since the S-layer glycome is connected with a molecular self-assembly system, there is a strong link to the field of nanobiotechnology, because means for organizing materials, such as biologically functional glycans, at the nanometer level are prime candidates for the production of supramolecular structures and devices [[51] ].
S-layer proteins functions
Synthesizing S-layer proteins is energy consuming and their productions are exquisitely regulated, suggesting that they each have a defined role [ [9] ]. However, no general function has been identified for S-layer proteins and many of the functions assigned are still hypothetical. Though they have been found in most of the phylogenetic branches of microorganisms, the function of S-layers is assumed specific for genera or groups of organisms in the same environment rather than common to all prokaryotes [ [9] ]. S-layers function as protective coatings, molecularsieves in the ultrafiltration range (constituting molecule and ion traps), promoters of cell adhesion and surface recognition, determiners of cell shape in archaea and some bacteria, Taking into account all above-mentioned Slayer functions that reinforce the probiotic properties of lactobacilli, characterization of different lactobacillar S-layer proteins is key to the selection of useful strains.
S-layer proteins in vaccine technology 4.1 S-layer proteins as immunogenic agents
One of the most relevant areas of research in nanobiotechnology is the technological utilization of self-assembly systems [[72] ]. Individual S-layer subunits contain all the information required for assembly into a regular array; isolated subunits can assemble into organized structures, resembling those observed on intact cells [ [15] ]. The natural assembly of S-layers into large regular arrays endows them with immune-stimulating and intrinsic-adjuvant properties [ [51] , [73] ]. The location of the foreign antigen within the S-layer protein may not be crucial for vaccine production, as long as sufficient amounts of expression are obtained and sheet-like structures are formed. The potential of S-layers as antigen carriers for vaccine preparations has been demonstrated [ [74] , [75] ]. Polysaccharides and proteins can be chemically linked to S-layers; the use of such conjugates induces immune responses in animal models. Insertion of foreign proteins into S-layers by genetic manipulation avoids the need for toxic chemicals and ensures the presence of these proteins in every S-layer protein subunit [[76] ]. T-cell-mediated immunity can be induced in BALB/c mice by Copyright [ [80] ] showed that a mixture of the L. brevis Slayer fusion proteins and the specific antibodies against coronavirus, rotavirus, Escherichia coli, and Salmonella typhimurium to newborn Hanwoo calves twice a day resulted in successful protection from neonatal calf diarrhea syndrome for about three weeks. This is the first report to treat neonatal calf diarrhea syndrome effectively using the recombinant Lactobacillus S-layer proteins. Thus, the results open promising applications of the bacterial Slayer proteins in the animal industry as well as in the bioindustry for protein immobilization [[80] ]. Konstantinov et al. [[81] ] recently established that the SlpA-dominant L. acidophilus NCFM interacts with a major receptor on dendritic cells and regulates its immune functions. It suggests that this probiotic bacterium could directly or indirectly interfere with pathogen-induced effects on the host immune system. These data establish a working hypothesis on the mode of action of probiotic cultures that will guide further investigations into the mechanisms by which these bacteria impact GI states. The work also suggests that the potential switch between Slayer proteins SlpA and SlpB might lead to differential immune responses impacting the gut immune homeostasis. Therefore, further studies need to address at what extent the ratio of SlpA to SlpB present on the surface of different intestinal LAB [[81] ].
Lactobacillar S-layer proteins and vaccine delivery
Lactobacilli have several properties that make them attractive candidates for mucosal vaccine-delivery vehicles. The intrinsic properties of lactobacilli to modulate the immune system make them attractive for health applications, in particular for the in vivo production and delivery of biologically active molecules [[82] ]. Modulation of the immune system can occur through the intrinsic adjuvanticity and cytokine-inducing properties of lactobacilli. Recently, there has been increased interest in the possibility of genetically manipulating lactobacilli, both for probiotic use [ [83] ] and for delivering mucosal vaccines [[84] ]. Various cellular locations have been tested for antigen production with lactococci and lactobacilli [ [85] , [86] ]. If Lactobacillus species could be engineered in such a way that each S-layer protein monomer was fused to a foreign antigen, the concentration of antigen at the bacterial surface would be very high. Identification and characterization of adherence factors has therefore become a topic of special interest [[87] ]. S-layer proteins can account for 10-12% of total cell proteins. This high level of expression facilitates large-scale production of target proteins. More importantly, since S-layer proteins are expressed on the cell surface and are either secreted or can be easily released from the cell surface, recovery and purification of S-layer fusion proteins is relatively simple [[88] ]. Smit et al. [[44] ] demonstrated that it is possible to surface-expose epitopes as part of the S-layer of L. acidophilus. Efficient transcription of S-layer protein genes is required, since synthesis of up to 5 x 105 Slayer protein subunits has been calculated to be required for complete formation of an Slayer on an average-sized cell [[89] ]. Studies in the activities of the two promoters of SlpA from L. brevis, by measuring reporter enzyme activities and transcript amounts in recombinant strains, showed the high expression levels of both slpA and the reporter genes. Furthermore, recombinant L. brevis strains remain on a substantially high level under conditions encountered in the gastrointestinal tract, by addition of bile or pancreatic extract in the growth medium, or after a change the carbon source. These findings encourage the research aiming at the use of L. brevis ATCC 8287 in live oral vaccines with its S-layer protein as an antigen carrier [ [90] ]. Similar results were found for slpA gene of L. acidophilus ATCC 4356, where slpA gene expression increased in the salt bile stress conditions [[91] ]. Furthermore, in S-layer proteins of L. brevis ATCC 8287 it was demonstrated that self-assembly domain comprises residues 179-435 in mature protein, since truncated proteins encompassing this region were able to form a periodic structure indistinguishable from that formed by full length SlpA. The mapping of surface exposed residues in the self-assembly domain of SlpA is currently in progress and is a potential tool for mucosal immunization, and further studies concerning vaccine development [92] . Small epitopes can be surface-displayed as part of the S-layer proteins of lactobacilli [ [92] , [44] An intact S-layer without any changes in crystalline structure can be formed even if there is a heterologous epitope in every S-layer subunit [ [92] ]. A poliovirus VP1 epitope and a cMyc epitope from the human c-myc protooncogene have been successfully surface displayed in L. brevis SlpA protein [ [92] , [44] ]. Recombinant L. brevis that displayed the c-Myc epitope in all of the S-layer protein subunits, without any effect on S-layer lattice structure, was obtained because of successful gene replacement [[92] ]. Surface display in S-layers would thus be a very efficient and safe means to present antigens to the mucosal-associated lymphoreticular tissue [[92] ]. Recently was showed that both slpA and slpB S-layer genes of L. crispatus ZJ001 expressed in E. coli with the addition of His tags, were adhesive to HeLa cells, although different in the structure of protein polymers. Therefore, the authors suggest that it is possible to explore the strain L. crispatus ZJ001 as a mucosal vaccine delivery vector, by engineering heterologous protein genes into slpA, because of the expression pattern and high cell binding ability of SlpA [[93] ].
Liposomes stabilized by S-layer proteins as vaccine carriers
Liposome-antigen and liposome-DNA vaccines have frequently been tested using systemic routes of administration; various new products based on this technology are presently in use or in clinical development [[94] ]. Biodegradability and low permeability to small hydrophilic molecules make liposomes excellent reservoirs for drug loading/release [ [95] ]. Development of effective delivery systems for the presentation of antigens to mucosal surfaces is critical to the success of vaccines [[96] ]. Particulate antigens are more effective than soluble antigens for the induction of systemic and mucosal immunity, possibly because of more efficient endocytosis of particulate antigens by mucosal-associated lymphoid tissue (MALT) [[97] ]. Liposomes are considered effective immunological adjuvants and have potential for intranasal and oral delivery of protein antigens [[98] ]. However, delivery of pharmaceuticals via an oral route, particularly biotechnology products such as proteins, peptides, genes, oligonucleotides and vaccines, remains problematic to this day. Instability in the gastrointestinal environment and poor permeability across the intestinal epithelial cell barrier contribute to the poor oral bioavailability of many of these compounds [[99] ]. Modulating the properties of vesicles by means of covalently or non-covalently attached or entrapped polymers [ [100] ] helps control their stability and permeability and imparts some specific surface properties [[95] ]. S-layer proteins of some Bacillus and Lactobacillus species can be crystallized on liposomes composed of various phospholipids together with cholesterol, leading to a novel type of liposome (Table 3) . Such S-layer coated liposomes are closed biomimetic structures that resemble archaeal cells, in which the S-layer proteins crystallize over the plasma membrane [[101] ]. Natural association of S-layers with the cytoplasmic membrane occurs only in Archaea, where S-layers are anchored by hydrophobic stretches of protein 'stalks' that presumably act as immobilization structures for lipids and proteins, with unknown consequences for membrane properties in vivo [ [13] , [102] ]. Interaction of S-layer proteins with lipid molecules is noncovalent. Electrostatic interaction between exposed carboxy groups on the inner face of the S-layer lattice and zwitterionic lipid head groups is primarily responsible for the binding and defined orientation of the S-layer subunits to form a closed lattice structure. It has been suggested that there are at least two to three contact points between the lipid film and the attached S-layer protein. Therefore, only a few lipid molecules would be anchored via their head groups to protein domains on the S-layer lattice; the remaining scores of lipid molecules diffuse freely in the membrane between the pillars consisting of anchored lipid molecules. Because of its fluid characteristic, this nanopatterned type of lipid membrane is also referred to as a 'semifluid membrane' [[103] ]. However, most importantly, the attached Slayer lattices apparently have no effect on the hydrophobic lipid acyl chains. Thus, S-layer lattices constitute unique scaffolding for lipid membranes [[104] ]. Use of these properties has potential for a broad spectrum of developments in many areas, including diagnostics, high-throughput screening for drug discovery, sensor technology, and electronic or optical devices; it might find application in DNA sequencing [[101] ]. S-layer proteins, after they have been crystallized on liposomes, can be cross-linked and exploited as a matrix for the covalent attachment of functional molecules, which would be useful for drug targeting or immunodiagnostic assays [[106] , [107] ]. Although currently the most extensively studied S-layer proteins are those of Geobacillus stearothermophilus PV72/p2 and Bacillus sphaericus CCM 2177, many relevant nanobiotechnological applications can be expected from the utilization of S-layer proteins from other organisms, in particular Lactobacillus [ [7] ]. In recent studies with Slayer proteins of lactobacilli, we demonstrated the existence of protein-liposome interactions. Using electron micrographs, we showed that Slayer proteins are adsorbed on the liposome layer, covering the entire surface [[109] ]. Furthermore, S-layer proteins isolated from GRAS lactobacilli are able to stabilize positively charged liposomes against different condition [45] . This effect could be explained by the concourse of different changes promoted by the proteins on the lipid bilayer. An increase in the bilayer packing due to charge neutralization decreases in the acyl chain mobility and hence permeability. In addition, S-layer proteins were able to decrease liposome fusion, probably to the inclusion of bulky moieties protruding from the membrane, giving place to steric hindrance for surface-surface interaction [[53] ]. Studies on Caco-2 monolayers using liposomes coated with S-layer proteins from L. kefiri showed absence of cytotoxicity and also that coated liposomes were able to transfer more fluorescent molecules than control ones (without S-layers proteins) [[110] ]. The natural adhesive properties of S-layer proteins to different epithelial cells probably promote the internalization, could explaining those results. The higher stability of S-layer-coated liposomes, combined with the adhesion and immunogenic functions of S-layer proteins, and the possibility for immobilizing or entrapping biologically active molecules [ [106] 
Conclusions and perspectives S-layers have been identified in several
Lactobacillus species. In some of these bacteria, S-layers have been shown to function as adhesins, mediating binding of lactobacilli to the host epithelial cells and/or ECM [ [4] ]. Due to these observed adhesive properties, including their high degree of structural regularity and their self-assembly properties, the possible therapeutic applications of lactobacillar S-layers have become increasingly of interest, e.g. as targeted antigen delivery vehicles to host tissues [ [86] , [111] , [107] ]. Slayers may provide superior expression levels and surface density of antigens when compared to other bacterial antigen presentation systems. It has already been demonstrated that S-layer protein subunits can be modified to carry foreign epitopes as a uniform recombinant S-layer on the lactobacilli cell surface [ [92] , [44] ]. The application of the intrinsic adjuvanticity of lactobacilli as hosts, in constructing these vaccine strains, may result in the stimulation of immune responses to a coadministered antigen, surface-displayed as a part of the S-layer. Further advantages in employing lactobacilli as surface-display vectors include the health-promoting properties claimed for several strains [ [112] ], the GRAS status of lactobacilli [ [113] ] and the lack of LPS in the cell wall, which eliminates the risk of endotoxic shock [[84] ]. However, there have been few immunization studies with Lactobacillus S-layer antigen constructs; favorable results from several immunization studies using recombinant S-layer proteins from other bacteria [ [76] , [88] ] encouraged us to develop Lactobacillus S-layer based antigen carriers. The adhesion and immunogenic functions of S-layer proteins, combined with the properties of Lactobacillus spp., could lead to new, safe, and stable liposomal particles for drug delivery. The high mechanical and thermal stability of S-layer-coated liposomes and the possibility for immobilizing or entrapping biologically active molecules [ [114] ] are important properties for liposome processing, as the vesicles have to resist processing manipulations, including stirring, pumping and resuspension, and they need to pass across the gastrointestinal tract. For medical applications, increased stability of liposomal preparations is essential for formulations that must be administered orally, because the liposomes will be exposed to a harsh environment [[109] ]. Another potential application for lactobacillar S-layers is in nanotechnology, in which self-assembly systems are exploited for the activation of surfaces as well as for the production of biomimetic membranes and encapsulation systems [ [7] ]. [115] . In bold underlined are indicated phylogenetic groups were S-layer carrying species have been reported. 
Organism

Lipid interface Reference
Lactobacillus brevis liposomes [53, 109] Lactobacillus kefiri liposomes [53, 109] Bacillus sphaericus lipid monolayer [128, 129] Geobacillus stearothemophilus liposomes [125] Bacillus coagulans liposomes [127] 
Effect on liposome Reference
Stabilization effects against Bile salt [109] Pancreatic extracts [109] Lower pH [109] Mechanical stress [125] Temperature stress [109, 125] Inversion of the ξ-potential in positively charged liposomes [109, 125] Stabilization of the liquid-ordered gel-like state [126] Ordering of the lipid molecules [53] Inhibition of spontaneous fusion [53] 
